Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-01 | Future report Set alerts | |
Q2 2022 | 2022-08-02 | -0.32 | -0.32 |
Q1 2022 | 2022-05-03 | -0.33 | -0.33 |
Q4 2021 | 2022-02-15 | -0.30 | -0.30 |
Q3 2021 | 2021-11-03 | 2.11 | 2.11 |
Q2 2021 | 2021-08-04 | -0.36 | -0.36 |
Q1 2021 | 2021-04-27 | -0.38 | -0.38 |
Q4 2020 | 2021-02-23 | -0.28 | -0.28 |
Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
Q2 2020 | 2020-07-28 | -0.20 | -0.20 |
2016-07-12 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-06-30 | Initiated Coverage | JMP Securities | Outperform | $25.00 |
2016-04-30 | Reiterated Rating | Needham & Company LLC | Buy | |
2016-03-29 | Initiated Coverage | Northland Securities | Outperform | $24.00 |
2016-03-14 | Reiterated Rating | Needham & Company LLC | Buy | $23.00 |
2016-03-01 | Reiterated Rating | BTIG Research | Buy | $28.00 |
2016-02-24 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2016-02-24 | Reiterated Rating | Needham & Company LLC | Buy | |
2016-02-24 | Reiterated Rating | Piper Jaffray | Outperform | $25.00 to $22.00 |
2016-02-24 | Reiterated Rating | Piper Jaffray Cos. | Outperform | $25.00 to $22.00 |
2016-01-11 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2015-11-10 | Reiterated Rating | BTIG Research | Buy | $30.00 |
2015-10-29 | Reiterated Rating | Canaccord Genuity | Buy | $28.00 |
2015-10-29 | Reiterated Rating | BTIG Research | Buy | $30.00 |
2015-10-28 | Lower Price Target | Needham & Company LLC | Buy | $30.00 to $23.00 |
2015-10-06 | Reiterated Rating | Leerink Swann | Buy | |
2015-10-06 | Lower Price Target | Canaccord Genuity | Buy | $31.00 to $28.00 |
2015-10-06 | Lower Price Target | Needham & Company LLC | Buy | $32.00 to $30.00 |
2015-10-05 | Reiterated Rating | BTIG Research | Buy | |
2015-10-05 | Lower Price Target | Canaccord Genuity | Buy | $31.00 to $28.00 |
2015-09-29 | Reiterated Rating | Canaccord Genuity | Buy | $31.00 |
2015-09-23 | Reiterated Rating | Needham & Company LLC | Buy | $32.00 |
2015-08-06 | Initiated Coverage | BTIG Research | Buy | $34.00 |
2015-08-04 | Reiterated Rating | Needham & Company LLC | Buy | $32.00 |
2015-07-30 | Reiterated Rating | Canaccord Genuity | Buy | $31.00 |
2015-07-29 | Boost Price Target | Stifel Nicolaus | Buy | $25.00 to $26.00 |
2015-07-29 | Reiterated Rating | Piper Jaffray | Buy | $23.00 to $30.00 |
2015-07-29 | Boost Price Target | Needham & Company LLC | Buy | $26.00 to $29.00 |
2015-07-28 | Boost Price Target | Dougherty & Co | Buy | $25.00 to $30.00 |
2015-05-01 | Reiterated Rating | Canaccord Genuity | Buy | $29.00 |
2015-03-25 | Boost Price Target | Canaccord Genuity | Buy | $26.00 to $28.00 |
2015-03-25 | Boost Price Target | Stifel Nicolaus | Buy | $22.00 to $25.00 |
2015-03-23 | Boost Price Target | Needham & Company LLC | Buy | $21.00 to $26.00 |
2015-03-18 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 to $28.00 |
2015-03-11 | Initiated Coverage | Dougherty & Co | Buy | $25.00 |
2015-03-09 | Initiated Coverage | Needham & Company LLC | Buy | $21.00 |
2015-02-25 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 |
2015-02-24 | Boost Price Target | Stifel Nicolaus | Buy | $20.00 to $22.00 |
2014-05-30 | Initiated Coverage | Stifel Nicolaus | Buy | $20.00 |
2014-02-28 | Boost Price Target | JMP Securities | $31.00 to $33.00 | |
2014-02-14 | Boost Price Target | Canaccord Genuity | $25.00 to $26.00 | |
2014-01-10 | Upgrade | JMP Securities | Market Perform to Outperform | |
2014-01-10 | Boost Price Target | Canaccord Genuity | $19.00 to $25.00 | |
2013-12-20 | Boost Price Target | Canaccord Genuity | $16.00 to $19.00 | |
2013-10-30 | Boost Price Target | Canaccord Genuity | Buy | $14.00 to $16.00 |
2012-08-03 | Downgrade | JMP Securities | Mkt Outperform to Mkt Perform | |
2011-12-21 | Reiterated | Kaufman Bros | Buy | $14 to $16 |
2011-09-22 | Initiated | Kaufman Bros | Buy | $14 |
2011-09-08 | Initiated | JMP Securities | Mkt Outperform | $16 |
2011-01-04 | Reiterated | Barrington Research | Outperform | $10 to $14 |
2010-06-09 | Initiated | Maxim Group | Buy | $7 |
2009-11-05 | Upgrade | Piper Jaffray | Underweight to Neutral | |
2009-02-20 | Reiterated | Roth Capital | Hold | $4 to $2 |
2009-02-20 | Reiterated | Canaccord Adams | Hold | $5.50 to $4.50 |
2008-11-03 | Downgrade | Roth Capital | Buy to Hold | $15 to $6.50 |
2008-04-23 | Initiated | BMO Capital Markets | Outperform | |
2008-02-28 | Initiated | Rodman & Renshaw | Mkt Outperform | $15 |
2008-02-15 | Reiterated | Stanford Research | Buy | $14 to $16 |
2008-01-02 | Reiterated | Roth Capital | Buy | $14 to $15 |
2007-12-20 | Initiated | Barrington Research | Outperform | $17 |
2007-12-19 | Initiated | Barrington Research | Outperform | $17 |
2007-10-09 | Initiated | Stanford Research | Buy | |
2007-02-16 | Reiterated | AG Edwards | Buy | $13 to $16 |
2016-07-12 | Reiterated Rating | Canaccord Genuity | Buy | |
2016-06-30 | Initiated Coverage | JMP Securities | Outperform | $25.00 |
2016-04-30 | Reiterated Rating | Needham & Company LLC | Buy | |
2016-03-29 | Initiated Coverage | Northland Securities | Outperform | $24.00 |
2016-03-14 | Reiterated Rating | Needham & Company LLC | Buy | $23.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ATRC 169 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 4.29M |
ALLIANCEBERNSTEIN L.P. | 4.05M |
BlackRock Inc. | 3.58M |
Invesco Ltd. | 3.21M |
FRED ALGER MANAGEMENT INC | 2.33M |
RS INVESTMENT MANAGEMENT CO LLC | 2.03M |
Champlain Investment Partners, LLC | 2.01M |
First Light Asset Management, LLC | 1.49M |
MACQUARIE GROUP LTD | 1.36M |
BlackRock Fund Advisors | 1.13M |
CREDIT SUISSE AG/ | 1.12M |
STATE STREET CORP | 1.05M |
TimesSquare Capital Management, LLC | 0.96M |
LOOMIS SAYLES & CO L P | 0.91M |
GANNETT WELSH & KOTLER | 0.88M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Discovery Group I, LLC | 5.90% (1621334) | ATRC / TESS / |
CARREL MICHAEL H President, CEO and Director | 2.59% (712221) | ATRC / |
ROBARDS KAREN P | 1.16% (318328) | ATRC / GHL / |
Seith Douglas J SVP of Sales and Marketing | 0.92% (253739) | ATRC / |
Wade M. Andrew Vice President, Finance | 0.65% (179757) | ATRC / |
Drachman David J President, CEO and Director | 0.53% (146000) | ATRC / |
Noznesky Justin J SVP, Mktg & Business Develop | 0.49% (135920) | ATRC / |
Lanning Mark R | 0.36% (99005) | ATRC / FRS / |
Privitera Salvatore Chief Technology Officer | 0.32% (87174) | ATRC / |
Hooven Michael D | 0.24% (67049) | ATRC / |
LUX ANDREW L V.P. & Chief Operating Officer | 0.24% (66549) | ATRC / |
Collar Mark A | 0.23% (63767) | ATRC / FFBC / |
Kennedy Patricia J VP, GM, International | 0.23% (63124) | ATRC / |
Lucky James L VP, Regulatory Affairs and QS | 0.19% (51250) | ATRC / |
Krell Elizabeth D | 0.07% (19967) | ATRC / |
Drake Scott William | 0.06% (16805) | ATRC / SPNC / |
PRESIDIO MANAGEMENT GROUP VIII L L C | 0.04% (11873) | ATRC / OMED / |
GROVES REGINA E | 0.04% (10469) | ATRC / |
JOHNSON B KRISTINE | 0.03% (9469) | ATRC / PJC / SPNC / |
WHITE ROBERT S. | 0.03% (8605) | ATRC / |
JOHNSTON RICHARD M | 0.02% (5805) | ATRC / |
WEHRWEIN SVEN | 0.02% (5805) | ATRC / ISNS / PRLB / SPSC / UPI / VSCI / |